Novo-Nordisk A/S revenue breakdown overview

Novo-Nordisk A/S revenue for the last year amounted to 34.38 B USD, the most of which — 31.84 B USD — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 22.45 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Novo-Nordisk A/S 18.88 B USD, and the year before that — 12.15 B USD.